CSPC Pharmaceutical Group Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| 600276 | Jiangsu Hengrui Medicine | Buy |
15
|
¥47.23 | ¥56.49 | 14.33% | 0 | ¥300.31B |
| BGNE | BeiGene | Buy |
6
|
$160.56 | $285.19 | 71.28% | 2 | $16.99B |
| 1801 | Innovent Biologics | Buy |
6
|
HK$39.90 | HK$50.72 | 27.82% | 6 | HK$62.07B |
| 600196 | Shanghai Fosun Pharmaceutical ... | Outperform |
16
|
¥24.19 | ¥33.57 | 7.90% | 1 | ¥56.48B |
| 600062 | China Resources Double-Crane P... | Buy |
16
|
¥23.11 | ¥26.00 | 11.38% | 0 | ¥22.23B |
| 4105 | TTY Biopharm Company | Hold |
18
|
NT$77.30 | NT$86.00 | 11.90% | 0 | NT$19.22B |
| PSTV | Plus Therapeutics | Buy |
11
|
$2.13 | $11.00 | 604.23% | 2 | $7.35M |